Prevalence of hypercalcemia among cancer patients in the United States

Hypercalcemia of malignancy (HCM) is a serious metabolic complication whose population‐based prevalence has not been quantified. Rates of HCM differ by tumor type, with highest rates reported in multiple myeloma and lowest among colorectal and prostate cancer patients. This analysis estimates HCM pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gastanaga, Victor M., Schwartzberg, Lee S., Jain, Rajul K., Pirolli, Melissa, Quach, David, Quigley, Jane M., Mu, George, Scott Stryker, W., Liede, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899051/
https://www.ncbi.nlm.nih.gov/pubmed/27263488
http://dx.doi.org/10.1002/cam4.749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899051/
https://www.ncbi.nlm.nih.gov/pubmed/27263488
http://dx.doi.org/10.1002/cam4.749

Ejemplares similares